Extended Treatment of Venous Thromboembolism

Clinical Advances in Hematology & Oncology May 2013, Volume 11, Issue 5 Jeffrey Weitz, MD Professor, Departments of Medicine and Biochemistry and Biomedical Sciences, McMaster University, Canada Research […]

Mesenchymal Stromal Cell Expansion for Cord-Blood Engraftment

Clinical Advances in Hematology & Oncology April 2013, Volume 11, Issue 4 Marcos de Lima, MD Medical Director, Hematologic Malignancies and Stem Cell Transplant Program, University Hospitals Seidman […]

The Coagulation Disorders of Severe Liver Disease

Clinical Advances in Hematology & Oncology March 2013, Volume 11, Issue 3 Antoni Sabaté, MD, PhD Professor of Anesthesia, Department of Anesthesiology, Reanimation and Pain Clinic, Hospital Universitari […]

Risk Factors of Cardiovascular Disease After Hematopoietic Cell Transplantation

Clinical Advances in Hematology & Oncology February 2013, Volume 11, Issue 2 Saro Armenian, DO, MPH Assistant Professor, Outcomes Research, Population Sciences, Medical Director, Pediatric Survivorship Clinic, Childhood […]

Evaluation and Management of Bleeding Risks With Athletic Activities in Children With Hemophilia

Clinical Advances in Hematology & Oncology January 2013, Volume 11, Issue 1 Carolyn Broderick, MBBS, PhD Senior Lecturer, UNSW Medicine, University of New South Wales, Sydney, Australia, Staff […]

Management of Neutropenia in Cancer Patients

Clinical Advances in Hematology & Oncology December 2012, Volume 10, Issue 12 H&O How common is neutropenia among cancer patients? ML The majority of cancer patients […]

Long-Term Outcomes After Autologous Stem Cell Transplantation in Patients With POEMS Syndrome

Clinical Advances in Hematology & Oncology November 2012, Volume 10, Issue 11 H&O What are the components of POEMS syndrome? AD POEMS stands for polyradiculoneuropathy, organomegaly, […]

Prevention of Graft-Versus-Host Disease

Ran Reshef, MD Assistant Professor of Medicine Abramson Cancer Center University of Pennsylvania Perelman School of Medicine Philadelphia, Pennsylvania H&O What is graft-versus-host disease? RR Graft-versus-host […]

Adverse Events Associated With Intravenous Iron Preparations: A Comparison of Reported Rates

George R. Bailie, PharmD, PhD Professor of Nephrology Pharmacy Albany College of Pharmacy and Health Sciences Albany, New York H&O What are the most common intravenous […]

Recent Advances in the Management of Atypical Hemolytic Uremic Syndrome

Spero R. Cataland, MD Associate Professor of Clinical Internal Medicine Division of Hematology Wexner Medical Center at the Ohio State University Columbus, Ohio H&O What is […]

Update in the Diagnosis and Management of Heparin-Induced Thrombocytopenia

Adam Cuker, MD, MS Assistant Professor of Medicine and of Pathology & Laboratory Medicine The Hospital of the University of Pennsylvania Penn Comprehensive Hemophilia and Thrombosis […]

Update in Paroxysmal Nocturnal Hemoglobinuria

Peter Hillmen, MD, PhD Consultant Haematologist Leeds Teaching Hospitals NHS Trust Leeds, United Kingdom H&O What is paroxysmal nocturnal hemoglobinuria? PH Paroxysmal nocturnal hemoglobinuria (PNH) is […]

Umbilical Cord Blood Transplantation in Cancer Therapy

Elizabeth Olson Hexner, MD, MSTR Assistant Professor of Medicine University of Pennsylvania School of Medicine Philadelphia, Pennsylvania H&O How is umbilical cord blood used in cancer […]

Research in Intraoperative Blood Salvage

Jonathan H. Waters, MD Chief Anesthesiologist Magee-Womens Hospital Pittsburgh, Pennsylvania H&O What is the process of intraoperative blood salvage? JW The process of intraoperative blood salvage […]

A Preventive Approach to the Management of Severe Hemophilia A

Leonard A. Valentino, MD Professor, Departments of Pediatrics, Internal Medicine, Immunology/Microbiology and Biochemistry Director, Section of Pediatric Hematology/Oncology Director, Rush Hemophilia and Thrombophilia Center Rush University […]

The Reemergence of Aspirin for the Prevention of Venous Thromboembolism

John Eikelboom, MD Associate Professor of Medicine Department of Hematology and Thromboembolism McMaster University Hamilton, Ontario H&O Historically, what was the role of aspirin in the […]

The Incidence of Venous Thromboembolism in Cancer Patients: A Real-World Analysis

Gary H. Lyman, MD, MPH Professor of Medicine Director, Comparative Effectiveness and Outcomes Research – Oncology Duke University School of Medicine and the Duke Cancer Institute […]

Chuvash Polycythemia: Diagnosis and Management

Victor R. Gordeuk, MD Sickle Cell Center University of Illinois at Chicago Chicago, Illinois H&O What is Chuvash polycythemia? VG Chuvash polycythemia is an inherited condition […]

Cyclic and Chronic Neutropenia: An Update on Diagnosis and Treatment

David C. Dale, MD Professor of Medicine, University of Washington Attending Physician, UWMC-Roosevelt General Internal Medicine Center Division of General Internal Medicine University of Washington Medical […]

Gaucher Disease: Hematologic and Oncologic Implications

Derralynn Hughes, MA (oxon), DPhil, MRCP, FRCPath Senior Lecturer in Haematology Royal Free Campus, University College, London London, England H&O What is Gaucher disease? DH Gaucher disease […]